2020-04-10 20:47:38

The PTW has announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BEAMSCAN MR Motorized 3D Water Phantom. The BEAMSCAN MR is now available on the market within the U.S. PTW has already completed the installation of the first item in North America located at the Princess Margaret Cancer Centre in Toronto, Ontario, Canada. This new addition will provide a dedicated, fully equipped solution for beam data commissioning and annual QA of MR-LINACS. The center in Toronto is one of the largest cancer centers in the world. It is home to two state-of-the-art MR-LINAC systems, one being the Elekta Unity machine, which offers BEAMSCAN MR compatibility. To read more information about the BEAMSCAN MR and PTW, read this article here.

OTHER ARTICLES:

• New MRI Study Links MASLD to Accelerated Brain Aging: What You Need to Know
• New PET and MRI Research Suggests Visceral Fat Reduction Could Help Prevent or Delay Alzheimer's Disease
• New Discovery in Matter-Antimatter Asymmetry
• Compact, Cost-Effective Laser-Powered Particle Accelerators: A Game Changer for the Industry
• Prenuvo Launches FDA-Cleared AI-Powered Whole Body MRI Screening Products
• Linear Particle Accelerators Market: A Thriving Industry with Expanding Horizons
• Prevention and Screening: Major Contributors to Saving Lives in Five Key Cancer Types
• Can AI Improve Early Detection of Breast Cancer in MRI Studies?
• BAT: A Revolutionary Garment Enhancing Radiation Safety for Healthcare Professionals
• Research Advocates for Advanced Precision Radiation Therapy in Lung Cancer